Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5 ; volume:24 ; number:1 ; day:8 ; month:8 ; year:2024 ; pages:1-8 ; date:12.2024
BMC infectious diseases ; 24, Heft 1 (8.8.2024), 1-8, 12.2024

Creator: Molina, Kyle C.
Webb, Brandon J.
Kennerley, Victoria
Beaty, Laurel E.
Bennett, Tellen D.
Carlson, Nichole E.
Mayer, David A.
Peers, Jennifer L.
Russell, Seth
Wynia, Matthew K.
Aggarwal, Neil R.
Ginde, Adit A.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12879-024-09708-z

URN: urn:nbn:de:101:1-2410272110216.286941440423

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Molina, Kyle C.
Webb, Brandon J.
Kennerley, Victoria
Beaty, Laurel E.
Bennett, Tellen D.
Carlson, Nichole E.
Mayer, David A.
Peers, Jennifer L.
Russell, Seth
Wynia, Matthew K.
Aggarwal, Neil R.
Ginde, Adit A.
SpringerLink (Online service)

Other Objects (12)

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

Remdesivir: A Review in COVID-19

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

$Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$$

Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

Remdesivir: A Review in COVID-19

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

$Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$$

Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

Remdesivir: A Review in COVID-19

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

$Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$$

Untersuchung der Nephrotoxizität von Remdesivir $in$ $vitro$

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

Remdesivir: A Review in COVID-19

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

Remdesivir: A Review in COVID-19

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives

Outcomes of high-risk adult outpatients treated with early remdesivir therapy during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron era: experiences from the national centre of Hungary

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

Remdesivir: A Review in COVID-19

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned

Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder

Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir

Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants

Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives

Related objects

Reset password